Detalhe da pesquisa
1.
Long-term risk of delayed postoperative Crohn's disease recurrence in patients with no or mild endoscopic recurrence at first assessment.
Eur J Clin Invest
; : e14219, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38647188
2.
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry.
Dig Dis
; 42(3): 257-264, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452742
3.
Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
Rev Esp Enferm Dig
; 116(3): 175-176, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37170572
4.
Incidence of herpes zoster in patients with inflammatory bowel disease. / Incidencia de herpes zóster en pacientes con enfermedad inflamatoria intestinal: estudio observacional y retrospectivo en dos hospitales españoles de tercer nivel.
Gastroenterol Hepatol
; 47(6): 598-604, 2024.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38316174
5.
Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease. / Percepción del impacto del tratamiento biológico endovenoso sobre el ámbito laboral y personal en pacientes con enfermedad inflamatoria intestinal.
Gastroenterol Hepatol
; 2024 May 07.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38723767
6.
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study). / Impacto de la mesalazina en la respuesta a la vacunación contra la COVID-19 en pacientes con enfermedad inflamatoria intestinal. Resultados de un estudio prospectivo multicéntrico de GETECCU (VACOVEII).
Gastroenterol Hepatol
; 2024 Jan 12.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38219960
7.
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort.
Gastroenterol Hepatol
; 2024 May 06.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38710465
8.
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
Am J Gastroenterol
; 118(7): 1237-1247, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36716287
9.
Mesalazine dose modification based on faecal calprotectin levels in patients with ulcerative colitis in clinical remission. / Modificación de la dosis de mesalazina en función de los niveles de calprotectina fecal en pacientes con colitis ulcerosa en remisión clínica.
Gastroenterol Hepatol
; 2023 Oct 06.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-37806344
10.
Impact of left atrial appendage closure in patients on anticoagulation for atrial fibrillation and recurrent or chronic gastrointestinal bleeding.
Gastroenterol Hepatol
; 46(8): 621-627, 2023 Oct.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36828118
11.
Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapy.
Gastroenterol Hepatol
; 46(3): 164-170, 2023 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36179946
12.
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study).
Gastroenterol Hepatol
; 2023 Nov 23.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38007154
13.
Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH).
Liver Int
; 42(5): 1109-1120, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220659
14.
Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic.
Dig Dis Sci
; 66(12): 4191-4196, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469807
15.
Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.
Aging Clin Exp Res
; 33(8): 2355-2359, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34164799
16.
Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?
Dig Dis Sci
; 65(7): 2036-2043, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31858325
17.
Correction to: Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry.
Surg Endosc
; 34(3): 1123, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292741
18.
Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry.
Surg Endosc
; 34(3): 1112-1122, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31144122
19.
Impact of pain associated with the subcutaneous administration of adalimumab.
Gastroenterol Hepatol
; 43(1): 9-13, 2020 Jan.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-31492425
20.
Paediatric to adult transition programme in inflammatory bowel disease, why do we need it? / Programa de transición pediátrica a adultos en EII, ¿por qué es necesario?
Gastroenterol Hepatol
; 47(1): 104-106, 2024 Jan.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-37977428